Andrew Wilner and Daniel Pelletier discuss the key elements of a protocol to improve the utility of MRI in following progression of disease in patients ... 'Treating the MRI' in Multiple Sclerosis; ...

A new proposal to change the current MRI criteria for the diagnosis of multiple sclerosis to include the symptomatic lesion has been put forward in hopes of identifying patients earlier.

“This is the first time that we have had the ability to measure glutamate toxicity in the brain in real time, which gives us a marker for monitoring disease progression as well as our treatment of the ...

Neema et al. Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis. Journal of Neuroimaging , 2008; DOI: 10.1111/j.1552-6569.2008.00296.x ...

Central MRI reading and coordinating was provided by Daniel Pelletier, MD, study author, associate professor of neurology and a member of the Multiple Sclerosis Research Group at UCSF.

Magnetic resonance imaging, or MRI, has revolutionized the diagnosis of multiple sclerosis. WebMD explains how MRI works in detecting MS abnormalities and tracking the progress of the disease.

By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and relapses that come with the disease.In a new Yale School of Medicine study, ...

MRI-based visualization of demyelinated CNS lesions is pivotal to the diagnosis and monitoring of multiple sclerosis (MS). The authors describe how advanced multimodal neuroimaging techniques are ...

A retrospective, five-year study of 1,314 patients with multiple sclerosis (MS) has found that atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which ...